Changing Patterns of Asthma Medication Use Related to US Food and Drug Administration Long-Acting Β2-Agonist Regulation From 2005-2011

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2015.09.057
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Changing Patterns of Glucose-Lowering Medication Use in VA Nursing Home Residents With Diabetes, 2005 to 2011

Journal of the American Medical Directors Association
MedicineHealth PolicyGerontologyGeriatricsNursing
2015English

Abediterol (LAS100977), a Novel Long-Acting Β2-Agonist: Efficacy, Safety and Tolerability in Persistent Asthma

Respiratory Medicine
PulmonaryRespiratory Medicine
2014English

PRS30 Inhaled Corticosteroid and Long-Acting Beta-Agonist Medication Compliance in Patients With Moderate and Severe Asthma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Report From the Cardiovascular and Renal Drugs Advisory Committee: US Food and Drug Administration; June 15-16, 2005; Gaithersburg, Md

Circulation
Cardiovascular MedicinePhysiologyCardiology
2005English

US Food and Drug Administration Reports of Pregnancy and Pregnancy-Related Adverse Events Associated With Isotretinoin

JAMA Dermatology
DermatologyMedicine
2019English

US Food and Drug Administration Disruption of Generic Drug Market Increases Hospital Costs

Anesthesia and Analgesia
AnesthesiologyPain Medicine
2018English

Potential Masking Effect on Dyspnoea Perception by Short- And Long-Acting Β2-Agonists in Asthma

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2002English

Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration

JAMA network open
Medicine
2019English

From the Food and Drug Administration

JAMA - Journal of the American Medical Association
Medicine
1986English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy